FLT1 - fms related receptor tyrosine kinase 1 Gene
Also Known as FLT; FLT-1; VEGFR1; VEGFR-1
Species: Homo sapiens
About FLT1
This gene has 9 transcripts (splice variants), 199 orthologues, 53 paralogues and is associated with 1 phenotype. Biased expression in placenta (RPKM 90.6), thyroid (RPKM 20.1) and 8 other tissues.
Summary
This gene encodes a member of the vascular endothelial growth factor receptor (VEGFR) family. VEGFR family members are Receptor Tyrosine Kinases (RTKs) which contain an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and a tyrosine kinase (TK) domain within the cytoplasmic domain. This protein binds to VEGFR-A, VEGFR-B and placental growth factor and plays an important role in angiogenesis and vasculogenesis. Expression of this receptor is found in vascular endothelial cells, placental trophoblast cells and peripheral blood monocytes. Multiple transcript variants encoding different isoforms have been found for this gene. Isoforms include a full-length transmembrane receptor isoform and shortened, soluble isoforms. The soluble isoforms are associated with the onset of pre-eclampsia.[provided by RefSeq, May 2009]
FLT1 Products (6)
| mRNA | Protein | Name |
|---|---|---|
| NM_002019.4 | NP_002010.2 | vascular endothelial growth factor receptor 1 isoform 1 precursor |
| XM_017020485.1 | XP_016875974.1 | vascular endothelial growth factor receptor 1 isoform X1 |
| XM_011535014.2 | XP_011533316.1 | vascular endothelial growth factor receptor 1 isoform X2 |
| NM_001160031.1 | NP_001153503.1 | vascular endothelial growth factor receptor 1 isoform 4 precursor |
| NM_001159920.2 | NP_001153392.1 | vascular endothelial growth factor receptor 1 isoform 2 precursor |
| NM_001160030.2 | NP_001153502.1 | vascular endothelial growth factor receptor 1 isoform 3 precursor |
FLT1 Protein Structure
Ig_2: Immunoglobulin domain (33 - 116)
Ig_2: Immunoglobulin domain (146 - 215)
Ig_2: Immunoglobulin domain (237 - 321)
I-set: Immunoglobulin I-set domain (351 - 410)
Ig_2: Immunoglobulin domain (444 - 544)
I-set: Immunoglobulin I-set domain (568 - 645)
I-set: Immunoglobulin I-set domain (662 - 748)
Pkinase_Tyr: Protein tyrosine kinase (827 - 1154)
- 0
- 300
- 600
- 900
- 1200
- 1338 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
vascular endothelial growth factor receptor 1 |
|
|
FLT1 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
FLT1 | P17948 | VEGFA | Homo sapiens | P15692 | 10543948 | |
|
Intra
|
FLT1 | P17948 | VEGFA | Homo sapiens | P15692 | 20660291 | |
|
Intra
|
FLT1 | P17948 | VEGFA | Homo sapiens | P15692-4 | 1312256 | |
|
Intra
|
FLT1 | P17948 | PGF | Homo sapiens | P49763 | 20660291 | |
|
Intra
|
FLT1 | P17948 | PGF | Homo sapiens | P49763 | 14684734 | |
|
Intra
|
FLT1 | P17948 | PTPRJ | Homo sapiens | Q12913 | 12771128 | |
|
Intra
|
FLT1 | P17948 | CBL | Homo sapiens | P22681 | 18273061 | |
|
Intra
|
FLT1 | P17948 | CRKL | Homo sapiens | P46109 | 23397142 |
Recombinant FLT1 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P70636 | VEGFR-1 Protein, Human (HEK293, Fc) | P17948-1 (S27-N756) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P73064 | VEGFR-1 Protein, Human (328a.a, HEK293, Fc) | P17948-4/NP_001153503.1 (S27-I328) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P73065 | VEGFR-1 Protein, Human (328a.a, HEK293, His) | P17948-4/NP_001153503.1 (S27-I328) | ≥ 90%, as determined by reducing SDS-PAGE. |
| HY-P73554 | VEGFR-1 Protein, Human (HEK293, His) | P17948-1 (S27-N756) | ≥ 90%, as determined by reducing SDS-PAGE. |
| HY-P78230 | VEGFR-1 Protein, Human (Biotinylated, HEK293, His-Avi) | P17948-1 (S27-N756) | ≥ 95%, as determined by Bis-Tris PAGE. |
| HY-P78537 | VEGFR-1 Protein, Human (HEK293, His-Avi) | P17948-1 (S27-N756) | ≥ 95%, as determined by Bis-Tris PAGE. |
FLT1 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P80928 | VEGF Receptor 1 Antibody (YA015) | WB, IHC-P, IP | Human, Mouse, Rat |
| HY-P80928A | VEGF Receptor 1 Antibody (YA015)(PBS only) | WB, IHC-P, IP | Human, Mouse, Rat |
| HY-P86547 | VEGF Receptor 1 Antibody (YA6239) | WB, IHC-P, ICC/IF, IP, ELISA | Human, Mouse, Rat |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Colorectal Cancer |
|
|
| Mild Pre-Eclampsia |
|
|
| Angiokeratoma Of Fordyce |
|
|
| Microvascular Complications Of Diabetes 1 |
|
|
| Capillary Disease |
|
|
| Central Retinal Vein Occlusion |
|
|
| Vein Disease |
|
|
| Bronchopulmonary Dysplasia |
|
|
| Intussusception |
|
|
| Retinal Vascular Disease |
|
|
| Capillary Hemangioma |
|
|
| Kuhnt-Junius Degeneration |
|
|
| Pancreatic Cancer |
|
|
| Glioblastoma |
|
|
| Diabetic Macular Edema |
|
|
| Retinal Artery Occlusion |
|
|
| Rosacea |
|
|
| Rubeosis Iridis |
|
|
| Retinal Ischemia |
|
|
| Hypertensive Encephalopathy |
|
|
| Ciliary Body Cancer |
|
|
| Heart Disease |
|
|
| Exudative Vitreoretinopathy 1 |
|
|
| Rhabdomyosarcoma |
|
|
| Placental Insufficiency |
|
|
| Corneal Neovascularization |
|
|
| Neovascular Glaucoma |
|
|
| Hemangioma |
|
|
| Myocardial Infarction |
|
|
| High Grade Glioma |
|
|
| Chorioamnionitis |
|
|
| Angiokeratoma Of Mibelli |
|
|
| Hellp Syndrome |
|
|
| Mesothelioma, Malignant |
|
|
| Malignant Ciliary Body Melanoma |
|
|
| Placental Abruption |
|
|
| Angiosarcoma |
|
|
| Endophthalmitis |
|
|
| Macular Retinal Edema |
|
|
| Blood Group, Globoside System |
|
|
| Pheochromocytoma |
|
|
| Melanoma |
|
|
| Malaria |
|
|
| Microvascular Complications Of Diabetes 5 |
|
|
| Squamous Cell Carcinoma, Head And Neck |
|
|
| Renal Cell Carcinoma, Nonpapillary |
|
|
| Myeloid Leukemia |
|
|
| Vascular Cancer |
|
|
| Anaplastic Astrocytoma |
|
|
| Thyroid Gland Cancer |
|
|
| Leukemia, Acute Myeloid |
|
|
| Gastroesophageal Junction Adenocarcinoma |
|
|
| Body Mass Index Quantitative Trait Locus 11 |
|
|
| Retinal Vascular Occlusion |
|
|
| Endometriosis |
|
|
| Degeneration Of Macula And Posterior Pole |
|
|
| Eclampsia |
|
|
| Pre-Eclampsia |
|
|
| Neonatal Anemia |
|
|
| Lung Cancer |
|
|
| Breast Cancer |
|
|
| Macular Degeneration, Age-Related, 1 |
|
|
| Arteriovenous Malformations Of The Brain |
|
|
| Angiokeratoma Circumscriptum |
|
|
| Nervous System Disease |
|
|
| Lung Non-Squamous Non-Small Cell Carcinoma |
|
|
| Prostate Cancer |
|
|
| Ischemia |
|
|
| Twin-To-Twin Transfusion Syndrome |
|
|
| Hypertension, Essential |
|
|
| Ovarian Cancer |
|
|
| Gastroesophageal Adenocarcinoma |
|
|
| Meningioma, Familial |
|
|
| Eye Disease |
|
|
| Severe Pre-Eclampsia |
|
|
| Placenta Accreta |
|
|
| Ovarian Hyperstimulation Syndrome |
|
|
| Placenta Disease |
|
|
| Diabetes Mellitus |
|
|
| Gastrointestinal Stromal Tumor |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Mus musculus | FLT1 | MGD | MGI:95558 |
| Bos taurus | FLT1 | VGNC | VGNC:29041 |
| Canis familiaris | FLT1 | VGNC | VGNC:40907 |
| Macaca mulatta | FLT1 | VGNC | VGNC:72678 |
| Felis catus | FLT1 | VGNC | VGNC:62298 |
| Rattus norvegicus | FLT1 | RGD | RGD:2621 |
| Others | FLT1 | NCBI |